Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2022
– Revenue of $1,471.1 Million Significantly Exceeds Guidance – – Organic Revenue Grows 9% Excluding COVID-19 Benefits – – More...
Day: January 9, 2022
Core One Labs Now Also Working to Biosynthesize DMT and Receives License
VANCOUVER, British Columbia, Jan. 08, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN:...
COVAXIN™ (BBV152) Booster Dose Study Demonstrates Robust Immune Responses and Long-Term Safety
Participants receiving a booster dose six months after second dose of COVAXIN™ saw significant increase (>10-fold across Alpha, Beta, Delta...